LAURA HEACOCK: Open Payments
NPI 1639627102 · DOYLESTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$198 in 5 payments from 5 companies in 2025. Trend: 2023 $119 · 2024 $72 · 2025 $198
Food & beverage: $105Education: $93
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 1 | $93 |
| Eisai Inc. | 1 | $34 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Genmab U.S., Inc. | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
Products named: Lenvima, DATROWAY, Tivdak, Padcev.
Industry payments across PA — which companies pay providers there.
